
Nephros Inc
NASDAQ:NEPH

Operating Margin
Nephros Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
US |
![]() |
Nephros Inc
NASDAQ:NEPH
|
37.4m USD |
5%
|
|
CN |
![]() |
Midea Group Co Ltd
SZSE:000333
|
560.3B CNY |
10%
|
|
CN |
![]() |
Gree Electric Appliances Inc of Zhuhai
SZSE:000651
|
267.1B CNY |
18%
|
|
CN |
![]() |
Haier Smart Home Co Ltd
SSE:600690
|
258B CNY |
8%
|
|
US |
S
|
Sharkninja Inc
NYSE:SN
|
16.8B USD |
11%
|
|
CN |
![]() |
Zhejiang Supor Co Ltd
SZSE:002032
|
42.8B CNY |
12%
|
|
CN |
![]() |
Beijing Roborock Technology Co Ltd
SSE:688169
|
42B CNY |
11%
|
|
KR |
![]() |
Coway Co Ltd
KRX:021240
|
7.8T KRW |
19%
|
|
CN |
E
|
Ecovacs Robotics Co Ltd
SSE:603486
|
39.7B CNY |
5%
|
|
US |
![]() |
Whirlpool Corp
NYSE:WHR
|
5.5B USD |
6%
|
|
CN |
H
|
Hangzhou Greatstar Industrial Co Ltd
SZSE:002444
|
38.4B CNY |
14%
|
Nephros Inc
Glance View
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 34 full-time employees. The company went IPO on 2004-09-21. The firm segments include Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment primarily develops and sells high performance water purification filters. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment is focused on the development of medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. The Company’s pathogen detection systems are portable, near real-time systems designed to provide actionable data for infection control teams and other organizations. Its subsidiaries include Nephros International Limited and Specialty Renal Products, Inc.

See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Nephros Inc's most recent financial statements, the company has Operating Margin of 5%.